Abstract
Background: Proton therapy (PT) has characteristics that enable the sparing of healthy, non-cancerous tissue surrounding the radiotherapy target volume better from radiation doses than conventional radiotherapy for patients with cancer. While this innovation entails investment costs, the information about the treatment costs per patient, especially during the start-up phase, is limited. This study aims to calculate the costs of PT at a single center during the start-up phase in the Netherlands. Methods: The cost of PT per patient was estimated for the treatment indications, head and neck cancer, breast cancer, brain cancer, thorax cancer, chordoma and eye melanoma. A time-driven activity-based costing analysis (TDABC), a methodology that calculates the costs of consumed healthcare resources by a patient, was conducted in a newly established PT center in the Netherlands (HPTC). Both direct (e.g., the human resource costs for medical staff) and indirect costs (e.g., the operating/interest costs, indirect human resource costs and depreciation costs) were included. A scenario analysis was conducted for short-term (2021), middle-term (till 2024) and long-term (after 2024) predicted patient numbers in the PT center. Results: The total cost of PT in 2020 at the center varied between EUR 12,062 for an eye melanoma course and EUR 89,716 for a head and neck course. Overall, indirect costs were the largest cost component. The high indirect costs implied the potential of the scale of economics; according to our estimation, the treatment cost could be reduced to 35% of the current cost when maximum treatment capacity is achieved. Conclusion: This study estimated the PT cost delivered in a newly operated treatment center. Scenario analysis for increased patient numbers revealed the potential for cost reductions. Nevertheless, to have an estimation that reflects the matured cost of PT which could be used in cost-effectiveness analysis, a follow-up study assessing the full-fledged situation is recommended.
Reference27 articles.
1. World Health Organization (2022, June 01). Global Health Expenditure Database. Available online: https://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS?name_desc=false.
2. Zorg, V.e. (2022, June 01). Zorguitgaven. Available online: https://www.vzinfo.nl/kanker#node-kosten-van-zorg-voor-kanker.
3. The cost of cancer in Europe 2018;Hofmarcher;Eur. J. Cancer,2020
4. Gelband, H., Jha, P., Sankaranarayanan, R., and Horton, S. (2015). Cancer: Disease Control Priorities, The International Bank for Reconstruction and Development/The World Bank © 2015 International Bank for Reconstruction and Development/TheWorld Bank. [3rd ed.].
5. Economic burden of cancer across the European Union: A population-based cost analysis;Leal;Lancet Oncol.,2013
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献